Non-Hodgkin's lymphomas, version 1.2013.
Publication
, Journal Article
Zelenetz, AD; Wierda, WG; Abramson, JS; Advani, RH; Andreadis, CB; Bartlett, N; Bellam, N; Byrd, JC; Czuczman, MS; Fayad, LE; Glenn, MJ ...
Published in: J Natl Compr Canc Netw
March 1, 2013
These NCCN Guidelines Insights summarize several key updates to the NCCN Guidelines for Non-Hodgkin's Lymphomas (NHL) and provide a discussion of the clinical evidence that support the updates. The updates discussed in this article feature recommendations for additional treatment options in patients with chronic lymphocytic leukemia and guidance surrounding the management of hepatitis virus reactivation/infections in high-risk patients with NHL undergoing antitumor therapy.
Duke Scholars
Published In
J Natl Compr Canc Netw
DOI
EISSN
1540-1413
Publication Date
March 1, 2013
Volume
11
Issue
3
Start / End Page
257 / 272
Location
United States
Related Subject Headings
- Virus Activation
- Thalidomide
- Oncology & Carcinogenesis
- Lymphoma, Non-Hodgkin
- Leukemia, Lymphocytic, Chronic, B-Cell
- Lenalidomide
- Humans
- Hepatitis C
- Hepatitis B virus
- Hepatitis B Surface Antigens
Citation
APA
Chicago
ICMJE
MLA
NLM
Zelenetz, A. D., Wierda, W. G., Abramson, J. S., Advani, R. H., Andreadis, C. B., Bartlett, N., … National Comprehensive Cancer Network. (2013). Non-Hodgkin's lymphomas, version 1.2013. J Natl Compr Canc Netw, 11(3), 257–272. https://doi.org/10.6004/jnccn.2013.0037
Zelenetz, Andrew D., William G. Wierda, Jeremy S. Abramson, Ranjana H. Advani, C Babis Andreadis, Nancy Bartlett, Naresh Bellam, et al. “Non-Hodgkin's lymphomas, version 1.2013.” J Natl Compr Canc Netw 11, no. 3 (March 1, 2013): 257–72. https://doi.org/10.6004/jnccn.2013.0037.
Zelenetz AD, Wierda WG, Abramson JS, Advani RH, Andreadis CB, Bartlett N, et al. Non-Hodgkin's lymphomas, version 1.2013. J Natl Compr Canc Netw. 2013 Mar 1;11(3):257–72.
Zelenetz, Andrew D., et al. “Non-Hodgkin's lymphomas, version 1.2013.” J Natl Compr Canc Netw, vol. 11, no. 3, Mar. 2013, pp. 257–72. Pubmed, doi:10.6004/jnccn.2013.0037.
Zelenetz AD, Wierda WG, Abramson JS, Advani RH, Andreadis CB, Bartlett N, Bellam N, Byrd JC, Czuczman MS, Fayad LE, Glenn MJ, Gockerman JP, Gordon LI, Harris NL, Hoppe RT, Horwitz SM, Kelsey CR, Kim YH, Krivacic S, LaCasce AS, Nademanee A, Porcu P, Press O, Pro B, Reddy N, Sokol L, Swinnen L, Tsien C, Vose JM, Yahalom J, Zafar N, Dwyer MA, Naganuma M, National Comprehensive Cancer Network. Non-Hodgkin's lymphomas, version 1.2013. J Natl Compr Canc Netw. 2013 Mar 1;11(3):257–272.
Published In
J Natl Compr Canc Netw
DOI
EISSN
1540-1413
Publication Date
March 1, 2013
Volume
11
Issue
3
Start / End Page
257 / 272
Location
United States
Related Subject Headings
- Virus Activation
- Thalidomide
- Oncology & Carcinogenesis
- Lymphoma, Non-Hodgkin
- Leukemia, Lymphocytic, Chronic, B-Cell
- Lenalidomide
- Humans
- Hepatitis C
- Hepatitis B virus
- Hepatitis B Surface Antigens